Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease

Neuroscience Letters

Volumn 469, Issue 1, 2010, Pages 6-10

  Padurariu, Manuela ^a   Ciobica, Alin ^b,c   Hritcu, Lucian ^c   Stoica, Bogdan ^a   Bild, Walther ^a   Stefanescu, Cristinel ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b ACADEMY OF ROMANIAN SCIENTISTS   (Romania)

^c ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

Author keywords

Alzheimer's disease; Mild cognitive impairment; Oxidative stress

Indexed keywords

ANTIOXIDANT; FREE RADICAL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; MILD COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; COGNITION DISORDERS; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 72649096229     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.11.033     Document Type: Article

References (41)

1. Aybek H., Ercan F., Aslan D., and Sahiner T. Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey. Clin. Biochem. 40 (2007) 172-176
2. Baldeiras I., Santana I., Proença M.T., Garrucho M.H., Pascoal R., Rodrigues A., Duro D., and Oliveira C.R. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease. J. Alzheimer's Dis. 15 (2008) 117-128
3. Beal M.F. Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 26 (2005) 585-586
4. Bermejo P., Martín-Aragón S., Benedí J., Susín C., Felici E., Gil P., Ribera J.M., and Villar A.M. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment. Free Radic. Res. 42 (2008) 162-170
5. Bourdel-Marchasson I., Delmas-Beauvieux M.C., Peuchant E., Richard-Harston S., Decamps A., Reignier B., Emeriau J.P., and Rainfray M. Antioxidant defenses and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 30 (2001) 235-241
6. Butterfield D.A., Reed T., Perluigi M., de Marco C., Coccia R., Cini C., and Sultana R. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci. Lett. 397 (2006) 170-173
7. Butterfield D.A., Reed T., Perluigi M., de Marco C., Coccia R., Keller J.N., Markesbery W.R., and Sultana R. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res. 1148 (2007) 243-248
8. Ceballos-Picot I., Merad-Boudia M., Nicole A., Thevenin M., Hellier G., Legran S., and Berr C. Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type-place of the extracellular glutathione peroxidase. Free Radic. Biol. Med. 20 (1996) 579-587
9. Christophersen B.O. Formation of monohydroxy-polyenic fatty acids from lipid peroxides by a glutathione peroxidase. Biochim. Biophys. Acta 164 (1968) 35
10. Dawe B., Procter A., and Philpot M. Concepts of mild cognitive impairment in the elderly and their relationship to dementia: a review. Int. J. Geriatr. Psychiatry 7 (1992) 473-479
11. DeKosky S.T., Williamson J.D., Fitzpatrick A.L., Kronmal R.A., Ives D.G., Saxton J.A., Lopez O.L., Burke G., Carlson M.C., Fried L.P., Kuller L.H., Robbins J.A., Tracy R.P., Woolard N.F., Dunn L., Snitz B.E., Nahin R.L., and Furberg C.D. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 300 (2008) 2253-2262
12. Dias A.C., Módulo C.M., Jorge A.G., Braz A.M., Jordão Jr. A.A., Filho R.B., de Paula J.S., and Rocha E.M. Influence of thyroid hormone on thyroid hormone receptor beta-1 expression and lacrimal gland and ocular surface morphology. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3038-3042
13. Fernandes M.A., Santana I., Januario C., Cunha L., and Oliveira C.R. Decreased superoxide dismutase in erythrocytes from patients with Alzheimer's disease. Med. Sci. Res. 21 (1993) 679-682
14. Galbusera C., Facheris M., Magni F., Galimberti G., Sala G., Tremolada L., Isella V., Guerini F.R., Apollonio I., Galli-Kienle M., and Ferrarese C. Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. Curr. Alzheimer Res. 1 (2004) 103-109
15. Greilberger J., Koidl C., Greilberger M., Lamprecht M., Schroecksnadel K., Leblhuber F., Fuchs D., and Oettl K. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease. Free Radic. Res. 42 (2008) 633-638
16. Ishrat T., Parveen K., Khan M.M., Khuwaja G., Khan M.B., Yousuf S., Ahmad A., Shrivastav P., and Islam F. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res. 1281 (2009) 117-127
17. Kawamoto E.M., Munhoz C.D., Glezer I., Bahia V.S., Caramelli P., Nitrini R., Gorjao R., Curi R., Scavone C., and Marcourakis T. Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease. Neurobiol. Aging 26 (2005) 857-864
18. Keller J.N., Schmitt F.A., Scheff S.W., Ding P., Chen Q., Butterfield D.A., and Markesbery W.R. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64 (2005) 1152-1156
19. Kelley B.J., and Knopman D.S. Alternative medicine and Alzheimer disease. Neurologist 14 (2008) 299-306
20. Lima E.S., Roland Ide A., Maroja Mde F., and Marcon J.L. Vitamin A and lipid peroxidation in patients with different forms of leprosy. Rev. Inst. Med. Trop. Sao Paulo 49 (2007) 211-214
21. Lovell M., Ehman W., Butler S., and Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45 (1995) 1594-1601
22. Lovell M.A., and Markesbery W.R. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J. Neurosci. Res. 85 (2007) 3036-3040
23. Maier C.M., and Chan P.H. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 8 (2002) 323-334
24. Mangialasche F., Polidori M., Monastero R., Ercolani S., Camarda C., Cecchetti R., and Mecocci P. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res. Rev. 8 (2009) 285-305
25. Mariani E., Polidori M.C., Cherubini A., and Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 827 (2005) 65-75
26. Mariani E., Monastero R., and Mecocci P. Mild cognitive impairment: a systematic review. J. Alzheimers Dis. 12 (2007) 23-35
27. Markesbery W.R., and Lovell M.A. 4-Hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19 (1998) 33-36
28. McKhan G., Drachman D., Folstein M., Katzman R., Price C., and Stardlan M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and human Services task force of Alzheimer's disease. Neurology 34 (1984) 939-944
29. Mecocci P., Mariani E., Cornacchiola V., and Polidori M.C. Antioxidants for the treatment of mild cognitive impairment. Neurol. Res. 26 (2004) 598-602
30. Mohs R.C., Rosen W.G., and Davis K.L. The Alzheimer's Disease Assessment Scale: an instrument for assessing treatment efficacy. Psychopharmacol. Bull. 19 (1983) 448-450
31. Noor R., Mittal S., and Iqbal J. Superoxide dismutase-applications and relevance to human diseases. Med. Sci. Monit. 8 (2002) RA210-RA215
32. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., and Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 759-767
33. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56 (1999) 303-308
34. Petersen R.C., Thomas R.G., Grundman M., Bennet D., Doody R., Ferris S., Galasko D., Jin S., Kaye J., Levey A., Pfeiffer E., Sano M., van Dyck C.H., and Thal L.J. Vitamin E and donepezil for the treatment of mild cognitive impairment Alzheimer's Disease Cooperative Study Group. N. Engl. J. Med. 352 (2005) 2379-2388
35. Praticò D., Clark C.M., Liun F., Lee V., and Trojanowski J.Q. Increase of brain oxidative stress in mild cognitive impairment. A possible predictor of Alzheimer disease. Arch. Neurol. 59 (2002) 972-976
36. Rosen B., Mohs R.C., and Davis K.L. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 141 (1984) 1356-1364
37. Schuessel K., Leutner S., and Cairns N.J. Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. J. Neural Transm. 111 (2004) 1167-1182
38. Sharma R., Yang Y., Sharma A., Awasthi S., and Awasthi Y.C. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid. Redox Signal. 6 (2004) 289-300
39. Solfrizzi V., D'Introno A., Colacicco A., Capurso C., Todarello O., Pellicani V., Capurso S., Pietrarossa G., Santamato V., Capurso A., and Panza F. Circulating biomarkers of cognitive decline and dementia. Clin. Chim. Acta 364 (2006) 91-112
40. Sultana R., Piroddi M., Galli F., and Butterfield D.A. Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment. Neurochem. Res. 33 (2008) 2540-2546
41. Tjalkens R.B., Luckey S.W., Kroll D.J., and Petersen D.R. Alpha,beta-unsaturated aldehydes increase glutathione S-transferase mRNA and protein: correlation with activation of the antioxidant response element. Arch. Biochem. Biophys. 359 (1998) 42-50